Alkermes PLC

ALKS88

High Quality

$29.34arrow_drop_up1.89%$0.54

High Quality

ALKS88

$29.34

arrow_drop_up1.89%$0.54

High Quality

Performance History

Key Stats
Open	$27.86
Prev. Close	$27.70
EPS	2.29
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

	LOW	HIGH
Day Range	27.64	29.19
52 Week Range	22.01	32.88

Ratios







EPS	2.29

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Alkermes PLC (ALKS)

Alkermes PLC (ALKS) is a biopharmaceutical company operating in the United States and internationally. The company, headquartered in Dublin, Ireland, focuses on developing and commercializing innovative medicines to address unmet medical needs. Alkermes PLC has a diverse portfolio of products in various therapeutic areas, including central nervous system disorders, addiction and mental health, and oncology. With a strong commitment to research and development, Alkermes PLC aims to deliver novel treatments to improve patient outcomes.

The stock price history of Alkermes PLC (ALKS) reflects the company's growth and market performance over time. Investors can track the ups and downs of the stock price to make informed decisions about buying or selling shares. It is essential to analyze the stock price history in conjunction with other factors, such as company news and market trends, to gain a comprehensive understanding of Alkermes PLC's financial performance.

Websitecall_made

Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
CEO: Mr. Richard F. Pops
Headquarters: Dublin
Employees: 2280
Exchange: NASDAQ

Keep an eye on Alkermes PLC

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Alkermes PLC's (ALKS) price per share?

The current price per share for Alkermes PLC (ALKS) is $29.34. The stock has seen a price change of $0.54 recently, indicating a 1.89% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Alkermes PLC (ALKS)?

For Alkermes PLC (ALKS), the 52-week high is $32.88, which is 12.05% from the current price. The 52-week low is $22.01, the current price is 33.33% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Alkermes PLC (ALKS) a growth stock?

Alkermes PLC (ALKS) has shown an average price growth of -3.36% over the past three years. It has received a score of 60 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Alkermes PLC as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Alkermes PLC (ALKS) stock price performance year to date (YTD)?

As of the latest data, Alkermes PLC (ALKS) has a year-to-date price change of 2.53%. Over the past month, the stock has experienced a price change of 9.29%. Over the last three months, the change has been 2.93%. Over the past six months, the figure is 22.17%. Looking at a longer horizon, the five-year price change stands at 37.06%.

help

Is Alkermes PLC (ALKS) a profitable company?

Alkermes PLC (ALKS) has a net income of $355.76M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 82.64% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 27.7% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $1.66B, with a revenue growth rate of 49.61%, providing insight into the company's sales performance and growth. The gross profit is $1.37B. Operating income is noted at $414.12M. Furthermore, the EBITDA is $520.33M.

help

What is the market capitalization of Alkermes PLC (ALKS)?

Alkermes PLC (ALKS) has a market capitalization of $4.87B. The average daily trading volume is 29.18, indicating the stock's liquidity and investor engagement.